Anaphylactic shock elicited by topical administration of bacitracin.
D000293:Adolescent; D000707:Anaphylaxis / Q000139:chemically induced*; D000818:Animals; D001414:Bacitracin / Q000008:administration & dosage / Q000009:adverse effects*; D003876:Dermatitis, Atopic / Q000188:drug therapy / Q000276:immunology; D004342:Drug Hypersensitivity / Q000209:etiology*; D005260:Female; D000882:Haplorhini; D006801:Humans; D007073:Immunoglobulin E / Q000032:analysis; D009824:Ointments; D011863:Radioimmunoassay; D012882:Skin Tests; D005719:gamma-Globulins / Q000032:analysis
D009824:Ointments; D005719:gamma-Globulins; D001414:Bacitracin; D007073:Immunoglobulin E